chronic hepatitis B

Ask MedXY AI

Latest news

Tag

GastroenterologyAHB-137chronic hepatitis B

AHB-137: First-in-Human Study Shows Promising Antiviral Activity and Safety in Chronic Hepatitis B Management

By MedXY|Aug 17, 2026

AHB-137, an antisense oligonucleotide targeting HBV mRNA, demonstrated safety, favorable pharmacokinetics, and rapid HBsAg reduction in healthy volunteers and chronic hepatitis B patients, supporting further clinical development.

Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen

Gastroenterologychronic hepatitis B

We use cookies

chronic hepatitis B

Latest news

AHB-137: First-in-Human Study Shows Promising Antiviral Activity and Safety in Chronic Hepatitis B Management

Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen

Functional Anti-preS1 Antibody Responses and Their Role in Viral Control in Chronic Hepatitis B

HBsAg Seroclearance Lowers Hepatocellular Carcinoma Risk Beyond Viral Suppression in Cirrhosis, but Does Not Reduce Hepatic Decompensation

Potent Viral Suppression and Safety of ALG-000184: Insights from a Phase 1 Trial in Chronic HBV Infection

Functional Cure Within Reach: GSK’s Bepirovirsen Meets Primary Endpoints in Pivotal Phase III Chronic Hepatitis B Trials

Elebsiran Combined with Pegylated Interferon Alfa for Chronic Hepatitis B: Advances from Phase 2 Clinical Trials

Sequential Pegylated Interferon after Bepirovirsen Lowers Relapse Risk in Chronic Hepatitis B: Insights from the B-Together Trial